347 related articles for article (PubMed ID: 21833990)
1. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury.
Kato S; Aoyama M; Kakita H; Hida H; Kato I; Ito T; Goto T; Hussein MH; Sawamoto K; Togari H; Asai K
J Neurosci Res; 2011 Oct; 89(10):1566-74. PubMed ID: 21833990
[TBL] [Abstract][Full Text] [Related]
2. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
Pérès EA; Valable S; Guillamo JS; Marteau L; Bernaudin JF; Roussel S; Lechapt-Zalcman E; Bernaudin M; Petit E
Exp Cell Res; 2011 Oct; 317(16):2321-32. PubMed ID: 21749867
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning.
Chen ZY; Wang L; Asavaritkrai P; Noguchi CT
J Neurosci Res; 2010 Nov; 88(14):3180-8. PubMed ID: 20806411
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.
Yoo JY; Won YJ; Lee JH; Kim JU; Sung IY; Hwang SJ; Kim MJ; Hong HN
J Neurosci Res; 2009 Jan; 87(1):150-63. PubMed ID: 18711747
[TBL] [Abstract][Full Text] [Related]
6. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.
Nagai A; Nakagawa E; Choi HB; Hatori K; Kobayashi S; Kim SU
J Neuropathol Exp Neurol; 2001 Apr; 60(4):386-92. PubMed ID: 11305874
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietin.
Lourhmati A; Buniatian GH; Paul C; Verleysdonk S; Buecheler R; Buadze M; Proksch B; Schwab M; Gleiter CH; Danielyan L
PLoS One; 2013; 8(10):e77182. PubMed ID: 24124607
[TBL] [Abstract][Full Text] [Related]
9. Expression of erythropoietin and angiogenic growth factors following inner ear injury of newborn rats.
Gross J; Moller R; Amarjargal N; Machulik A; Fuchs J; Ungethüm U; Kuban RJ; Henke W; Haupt H; Mazurek B
Prague Med Rep; 2009; 110(4):310-31. PubMed ID: 20059883
[TBL] [Abstract][Full Text] [Related]
10. ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin.
Park MH; Lee SM; Lee JW; Son DJ; Moon DC; Yoon DY; Hong JT
Biochem Biophys Res Commun; 2006 Jan; 339(4):1021-8. PubMed ID: 16337149
[TBL] [Abstract][Full Text] [Related]
11. Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders.
Diaz Z; Assaraf MI; Miller WH; Schipper HM
J Neurochem; 2005 Apr; 93(2):392-402. PubMed ID: 15816862
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
[TBL] [Abstract][Full Text] [Related]
13. Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative.
Kako E; Kaneko N; Aoyama M; Hida H; Takebayashi H; Ikenaka K; Asai K; Togari H; Sobue K; Sawamoto K
Stem Cells; 2012 Oct; 30(10):2234-47. PubMed ID: 22890889
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia.
Knabe W; Sirén AL; Ehrenreich H; Kuhn HJ
Anat Embryol (Berl); 2005 Oct; 210(3):209-19. PubMed ID: 16151855
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
16. Calcium receptor expression and function in oligodendrocyte commitment and lineage progression: potential impact on reduced myelin basic protein in CaR-null mice.
Chattopadhyay N; Espinosa-Jeffrey A; Tfelt-Hansen J; Yano S; Bandyopadhyay S; Brown EM; de Vellis J
J Neurosci Res; 2008 Aug; 86(10):2159-67. PubMed ID: 18438915
[TBL] [Abstract][Full Text] [Related]
17. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-α.
Su Z; Yuan Y; Chen J; Zhu Y; Qiu Y; Zhu F; Huang A; He C
J Neurotrauma; 2011 Jun; 28(6):1089-100. PubMed ID: 21309692
[TBL] [Abstract][Full Text] [Related]
18. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation.
Sugawa M; Sakurai Y; Ishikawa-Ieda Y; Suzuki H; Asou H
Neurosci Res; 2002 Dec; 44(4):391-403. PubMed ID: 12445627
[TBL] [Abstract][Full Text] [Related]
19. Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress.
Liu J; Narasimhan P; Song YS; Nishi T; Yu F; Lee YS; Chan PH
Glia; 2006 Mar; 53(4):360-5. PubMed ID: 16288465
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
